VANGUARD GROUP INC - BIODELIVERY SCIENCES INTL IN ownership

BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 76 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BIODELIVERY SCIENCES INTL IN
ValueSharesWeighting
Q4 2021$14,701,000
-13.5%
4,742,364
+0.8%
0.00%
Q3 2021$16,992,000
-5.2%
4,707,051
-6.0%
0.00%
Q2 2021$17,921,000
-13.1%
5,006,015
-5.1%
0.00%
-100.0%
Q1 2021$20,616,000
+2.1%
5,272,680
+9.7%
0.00%0.0%
Q4 2020$20,193,000
+17.5%
4,808,108
+4.4%
0.00%0.0%
Q3 2020$17,183,000
-15.9%
4,606,719
-1.7%
0.00%0.0%
Q2 2020$20,442,000
+39.7%
4,688,472
+21.4%
0.00%0.0%
Q1 2020$14,636,000
-39.3%
3,861,710
+1.2%
0.00%0.0%
Q4 2019$24,126,000
+52.9%
3,817,371
+1.8%
0.00%0.0%
Q3 2019$15,781,000
-0.0%
3,748,430
+10.4%
0.00%0.0%
Q2 2019$15,788,000
+14.5%
3,395,428
+30.5%
0.00%0.0%
Q1 2019$13,792,000
+46.6%
2,602,249
+2.3%
0.00%
Q4 2018$9,411,000
+41.2%
2,543,499
+6.8%
0.00%
Q3 2018$6,666,000
-4.8%
2,380,456
+0.3%
0.00%
Q2 2018$7,000,000
+32.0%
2,372,856
+0.7%
0.00%
Q1 2018$5,303,000
-24.1%
2,356,987
-0.4%
0.00%
Q4 2017$6,983,000
+2.2%
2,367,160
+2.2%
0.00%
Q3 2017$6,835,000
+24.5%
2,316,877
+18.2%
0.00%
Q2 2017$5,488,000
+27.2%
1,960,130
-13.7%
0.00%
Q1 2017$4,315,000
+10.7%
2,271,519
+2.0%
0.00%
Q4 2016$3,898,000
-28.9%
2,227,483
+9.6%
0.00%
Q3 2016$5,486,000
+24.3%
2,031,599
+8.6%
0.00%
Q2 2016$4,414,000
-25.8%
1,870,186
+1.6%
0.00%
Q1 2016$5,945,000
-33.1%
1,840,309
-0.8%
0.00%
-100.0%
Q4 2015$8,887,000
-96.8%
1,855,176
-82.1%
0.00%
-90.0%
Q3 2015$279,776,000
+2001.2%
10,345,390
+518.5%
0.01%
+900.0%
Q2 2015$13,315,000
-20.7%
1,672,598
+4.6%
0.00%0.0%
Q1 2015$16,789,000
-7.3%
1,598,924
+6.1%
0.00%0.0%
Q4 2014$18,108,000
-18.9%
1,506,475
+15.4%
0.00%
-50.0%
Q3 2014$22,319,000
+56.8%
1,305,958
+10.8%
0.00%
+100.0%
Q2 2014$14,230,000
+57.4%
1,178,920
+10.1%
0.00%0.0%
Q1 2014$9,039,000
+86.6%
1,070,949
+30.2%
0.00%
Q4 2013$4,844,000
+12.2%
822,422
+3.4%
0.00%
Q3 2013$4,317,000
+43.6%
795,079
+7.4%
0.00%
Q2 2013$3,006,000740,4010.00%
Other shareholders
BIODELIVERY SCIENCES INTL IN shareholders Q4 2013
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,575,000$6,615,0004.38%
1492 Capital Management LLC 790,863$3,322,0001.91%
Rubric Capital Management LP 3,516,124$14,768,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,530,000$40,026,0000.79%
Zebra Capital Management LLC 144,241$606,0000.77%
KNOTT DAVID M 370,230$1,555,0000.70%
Nantahala Capital Management 5,123,671$21,519,0000.67%
SYSTEMATIC FINANCIAL MANAGEMENT LP 3,593,893$15,094,0000.66%
EMC Capital Management 98,933$416,0000.32%
ALGERT GLOBAL LLC 175,170$736,0000.21%
View complete list of BIODELIVERY SCIENCES INTL IN shareholders